EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection

The discovery of activating mutations in EGFR and KRAS in a subset of lung adenocarcinomas was a major advance in our understanding of lung adenocarcinoma biology, and has led to groundbreaking studies that have demonstrated the efficacy of tyrosine kinase inhibitor therapy. Fine-needle aspirates an...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mod Pathol
Главные авторы: Chowdhuri, Sinchita Roy, Xi, Liqiang, Pham, Trinh Hoc-Tran, Hanson, Jeffrey, Rodriguez-Canales, Jaime, Berman, Arlene, Rajan, Arun, Giaccone, Giuseppe, Emmert-Buck, Michael, Raffeld, Mark, Filie, Armando C
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470622/
https://ncbi.nlm.nih.gov/pubmed/22157931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2011.184
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы